EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quinobenzothiazine–AZT Hybrids Linked via 1,2,3-Triazole: Rational Design, Synthesis, and Biological Evaluation as Anticancer Agents

Klaudia Giercuszkiewicz-Haśnik iD, Magdalena Skonieczna iD, Beata Morak-Młodawska iD, Małgorzata Jeleń iD

International Journal of Molecular Sciences · 19.06.2026 · 27 (12) · 5562

DOI: 10.3390/ijms27125562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.06.2026. Verfasst von Klaudia Giercuszkiewicz-Haśnik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology and Engineering, Silesian University of Technology, Akademicka Street 16, 44-100 Gliwice, Poland. Hauptthemen laut MEDLINE: Antineoplastic Agents, Zidovudine, Triazoles. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia, Silesian University of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second leading cause of cancer-related deaths, while its resistance to treatment continues to represent a major therapeutic challenge. In the present study, a series of phenothiazine derivatives, including hybrids containing a 1,2,3-triazole linker and the zidovudine (AZT) fragment, were synthesized and evaluated for their anticancer activity against colorectal cancer cell lines HCT116 and HT-29 as well as non-cancerous BEAS-2B cells. Cytotoxic activity was determined using the Alamar Blue assay, while the mechanisms of action were investigated by flow cytometric analysis of apoptosis, cell cycle progression, and reactive oxygen species (ROS) generation. Additionally, changes in the expression of genes associated with apoptosis, oxidative stress, and DNA damage response were analyzed by RT-qPCR. The obtained results demonstrated that AZT-containing derivatives exhibited stronger anticancer activity than non-conjugated phenothiazine analogs. Compounds A9–A12 induced pronounced apoptosis and significant disturbances in cell cycle progression, particularly in HCT116 cells. Among the analyzed derivatives, compound A9 displayed the most favorable overall biological profile, combining strong proapoptotic and cytotoxic activity with relatively high selectivity toward cancer cells and moderate effects on non-cancerous cells. The results indicate that molecular hybridization of phenothiazine derivatives with the AZT scaffold represents a promising strategy for the development of novel anticancer agents targeting colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsZidovudineTriazolesHumansApoptosisReactive Oxygen SpeciesDrug DesignCell CycleHCT116 CellsCell Line, TumorPhenothiazinesDNA DamageColorectal NeoplasmsHT29 CellsCell Proliferation

Stichwörter der Autor:innen

anticancer activityapoptosiscell cycle arrestcolorectal cancerphenothiazine derivativeszidovudine (AZT)

Substanzen

Antineoplastic AgentsZidovudineTriazolesReactive Oxygen SpeciesPhenothiazines

Autor:innen und Institutionen

  • Department of Systems Biology and Engineering, Silesian University of Technology, Akademicka Street 16, 44-100 Gliwice, Poland.
  • Centre of Biotechnology, Silesian University of Technology, Krzywoustego Street 8, 44-100 Gliwice, Poland.
  • Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
  • Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska Street 4, 41-200 Sosnowiec, Poland.

ORCID-Profile: Klaudia Giercuszkiewicz-Haśnik, Magdalena Skonieczna, Beata Morak-Młodawska, Małgorzata Jeleń

Förderung

  • Medical University of Silesia
  • Silesian University of Technology

Zitieren

APA

Giercuszkiewicz-Haśnik, K., Skonieczna, M., Morak-Młodawska, B., & Jeleń, M. (2026). Quinobenzothiazine–AZT Hybrids Linked via 1,2,3-Triazole: Rational Design, Synthesis, and Biological Evaluation as Anticancer Agents. International Journal of Molecular Sciences, 27(12), 5562. https://doi.org/10.3390/ijms27125562

Vancouver

Giercuszkiewicz-Haśnik K, Skonieczna M, Morak-Młodawska B, Jeleń M. Quinobenzothiazine–AZT Hybrids Linked via 1,2,3-Triazole: Rational Design, Synthesis, and Biological Evaluation as Anticancer Agents. International Journal of Molecular Sciences. 2026;27(12):5562. doi:10.3390/ijms27125562

BibTeX
@article{GiercuszkiewiczHanik2026,
  author = {Giercuszkiewicz-Haśnik, Klaudia and Skonieczna, Magdalena and Morak-Młodawska, Beata and Jeleń, Małgorzata},
  title = {Quinobenzothiazine–AZT Hybrids Linked via 1,2,3-Triazole: Rational Design, Synthesis, and Biological Evaluation as Anticancer Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5562},
  doi = {10.3390/ijms27125562}
}
Kostenlos starten →